Mounjaro KwikPen Pre-Filled Pen

Mounjaro KwikPen Pre-Filled Pen

Mounjaro KwikPen is a prescription medication designed to help adults manage Type 2 Diabetes Mellitus (T2DM). It combines two powerful mechanisms—activating both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors—through its active ingredient, tirzepatide. This unique approach aids in controlling blood sugar levels and may also support weight loss efforts.

Benefits:

• Effectively lowers blood sugar levels when combined with a healthy diet and exercise.
• May contribute to weight reduction in people with T2DM.
• Targets both GIP and GLP-1 receptors to enhance insulin secretion and support appetite regulation.
• Helps to stabilize blood glucose levels over time.
• The KwikPen pre-filled pen delivers a hassle-free, easy-to-use injection option for those on weekly doses, enhancing convenience and supporting consistent adherence to treatment.

Dosage:

• The initial dose is 2.5 mg once weekly for the first 4 weeks, allowing the body to adjust.
• After the first 4 weeks, the dose is increased to 5 mg once a week. Continue with this dose for at least 4 weeks before considering further adjustments based on the patient’s progress and tolerance.
• Dosing may be modified to ensure optimal blood sugar management.

Warnings and Precautions:

• Notify your healthcare provider if you have a history of pancreatitis or Type 1 Diabetes Mellitus.
• Not recommended for people with a history of pancreatitis.
• Caution is advised for those with severe kidney conditions.
• Discuss possible drug interactions and any concerns about side effects with your healthcare provider.
• Keep an eye out for symptoms of pancreatitis, a rare but serious condition that requires immediate medical attention.

Usage Instructions:

• Administer Mounjaro KwikPen as a weekly injection, ideally on the same day each week.
• Inject subcutaneously (under the skin) in the thigh, abdomen, or upper arm.
• Carefully follow the injection instructions provided by your healthcare provider or the product’s guidelines.

Storage Information:

• Keep the pre-filled pen refrigerated at 36°F to 46°F (2°C to 8°C).
• Do not freeze the medication.
• After the pen is opened, it can be kept at room temperature (below 86°F / 30°C) for up to 21 days.
• Always store out of the reach of children.

Common Side Effects:

• Nausea
• Vomiting
• Diarrhea
• Decreased appetite
• Injection site reactions (redness, swelling, itching)
• If you experience severe abdominal pain, nausea, or vomiting, which may indicate pancreatitis, seek immediate medical assistance.

Information about Mounjaro:

• Product Monograph – Health Canada
• U.S. Food and Drug Administration Medication Guide